1. Home
  2. ICHR vs MDXG Comparison

ICHR vs MDXG Comparison

Compare ICHR & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ichor Holdings

ICHR

Ichor Holdings

HOLD

Current Price

$17.64

Market Cap

605.5M

Sector

Technology

ML Signal

HOLD

Logo MiMedx Group Inc

MDXG

MiMedx Group Inc

HOLD

Current Price

$7.07

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ICHR
MDXG
Founded
1999
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
605.5M
1.0B
IPO Year
2016
N/A

Fundamental Metrics

Financial Performance
Metric
ICHR
MDXG
Price
$17.64
$7.07
Analyst Decision
Buy
Buy
Analyst Count
5
2
Target Price
$26.50
$11.00
AVG Volume (30 Days)
638.1K
773.5K
Earning Date
02-03-2026
10-29-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.27
Revenue
$957,337,000.00
$393,442,000.00
Revenue This Year
$13.65
$19.13
Revenue Next Year
$5.40
$2.11
P/E Ratio
N/A
$26.84
Revenue Growth
16.86
14.77
52 Week Low
$13.12
$5.79
52 Week High
$35.56
$9.71

Technical Indicators

Market Signals
Indicator
ICHR
MDXG
Relative Strength Index (RSI) 51.53 50.25
Support Level $16.61 $6.62
Resistance Level $18.99 $7.45
Average True Range (ATR) 0.79 0.25
MACD 0.08 0.03
Stochastic Oscillator 45.69 51.52

Price Performance

Historical Comparison
ICHR
MDXG

About ICHR Ichor Holdings

Ichor Holdings Ltd is engaged in the design, engineering, and manufacturing of critical fluid delivery subsystems and components for semiconductor capital equipment. The product offerings include gas and chemical delivery subsystems, collectively known as fluid delivery subsystems, which are key elements of the process tools used in the manufacturing of semiconductor devices. The company also manufactures machined components, weldments, and proprietary products for use in fluid delivery systems. Geographically, the company operates in the United States, Singapore, Europe, and Others, of which a majority of the revenue is generated from Singapore.

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

Share on Social Networks: